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SUMM ARY 
 
Purpose: To analyze the relationship between increasing systemic blood pressure and 
right ventricular function by means of Tissue-Doppler Imaging (TDI) and Two-
dimesional Strain echocardiographic techniques. 
Subjects and methods: Ninety-eight never-treated, nonobese patients with blood 
pressure values varying from the optimal to the mild hypertensive range were recruited. 
Peak early (Em) and late (Am) diastolic  and systolic (Sm) velocities were recorded at 
the tricuspid and mitral annuli by TDI. Longitudinal peak strain and strain rate (SR) 
were sampled by speckle-tracking methodology at the right ventricle (RV) free wall and 
interventricular septum (IVS) and RV and left ventricular (LV) structure and function 
were evaluated by conventional echo-Doppler sonography. Insulin sensitivity was tested 
by homeostasis model assessment (HOMA) index. Data were analyzed by 24-h systolic 
BP (SBP) (cut-offs 117 and 130 mmHg), thus partitioning an optimal BP from an 
intermediate high-normal and an upper mildly increased BP stratum. 
Results: Em decreased in the mid-third and decelerated further in association with 
reduced Sm in the upper BP tertile; both correlated negatively to septal thickness and 
positively to homologous TDI-derived LV indices. RV peak systolic strain and early 
diastolic SR decreased in the mid-BP third without further changes in the upper tertile. 
IVS thickened gradedly by increasing systemic 24-h SBP; posterior wall remodelled to 
a lesser extent and poorly related to BP load and LV mass index did not change. RV and 
IVS systolic and diastolic strain indices associated inversely with increasing septal 
thickness. RV and LV indices of global ventricular function, estimated pulmonary 
pressure, HOMA did not differ by systemic BP. 
Conclusion: TDI and 2D-strain echocardiography showed a RV diastolic and systolic 
function impairment in response to slightly increased systemic BP. The process 
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paralleled homologous changes at the LV side and was driven by interventricular 
septum remodeling, perhaps as a reflection of its role in RV function and biventricular 
interdependence. Insulin sensitivity seemed to play no relevant role. 
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INTRODUCTION 
 
II. The right ventricle in systemic hypertension 
Chronically elevated systemic blood pressure (BP) has profound consequences on the 
heart and systemic vessels. Through the activation of a complex and interrelated series 
of biological mechanisms [1,2], the left ventricle (LV) undergoes geometric remodelling 
[3] and hypertrophies [4] while decreased compliance and delayed isometric relaxation 
impair left ventricular diastolic function, this latter occurring even in early hypertensive 
stages and in absence of left ventricular hypertrophy (LVH) [5]. Arterial hypertension 
also reshapes the more distal sites of the peripheral vasculature through faster vascular 
growth, eutrophic remodelling and changed distensibility [6]. As a consequence, 
resistance-sized arterioles increase their wall/lumen ratio, a structural modification that, 
on one hand, amplifies nonspecifically vasoconstrictor responses and, on the other, 
initiates and maintains a vicious circle heading towards a stable increase in peripheral 
vascular resistance, the hallmark of hypertensive disease [7]. The wide-ranging effects 
of BP elevation on the leftsided cardiovascular system, as above capsulized, are 
documented by a huge amount of basic and clinical research. However, sparser data 
scattered across at least 3 decades also point out to the presence of abnormalities of the 
right-sided cardiovascular system during the course of systemic hypertension, an 
important and rather overlooked body of information [8]. 
 
II.a A synopsis of the anatomy and the function of the right-sided cardiovascular system 
The right ventricle (RV) is a thin-walled, crescent-like chamber originating from the 
juxtaposition of a concave anterior free wall with a convex interventricular septum (Fig. 
1) [9]. The RV mass is about one-sixth of the LV and performs about one-quarter of its 
stroke work to propel blood across a vascular circuit whose resistance is about one-tenth 
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of the systemic values due to the large cross-sectional area of the pulmonary circulation 
[10].  
Anatomically, the RV is separated in an inflow and an outflow tract, the latter being 
responsible for the systolic ejection of the stroke volume. Because of the lower 
intraventricular pressure regimens and in contrast with the phasic perfusion of the LV, 
blood flows across the RV during both systole and diastole through the right coronary 
artery and its main branches, the conus artery, the acute marginal branches and the 
posterior descending artery with an additional contribution of the left anterior 
descending coronary artery to the right anterior wall [10]. As compared with its left 
counterpart, the RV has a lower volume-to-surface area ratio in agreement with its 
highly compliant nature adapted to accept large volumes of blood with negligible 
changes in pressure. Not surprisingly, therefore, the acutely overloaded right ventricular 
chamber first dilates to compensate for the reduced cardiac output and, eventually, fails. 
On the contrary, chronic pulmonary pressure overload stimulates a rather stereotyped 
adaptive response consisting of compensatory RV hypertrophy (RVH) characterized by 
a thicker wall and flattened interventricular septum with a relative impairment of 
coronary perfusion [11]. Independent of the underlying causal mechanism, long-term 
increase in pulmonary resistance originates from both functional components due to an 
unbalanced production of endothelium- derived vasoactive mediators (e.g. nitric oxide, 
prostacyclin, endothelin-1) and structural remodelling of pulmonary arterioles caused by 
proliferating endothelial cells, vascular smooth muscle cells and fibroblasts [11]. RV 
and LV are functionally and structurally interdependent [12] with the ultimate goal to 
provide sufficient lung/peripheral perfusion during rapidly changing physiological 
conditions. That goal is reached by a shared anatomic array of spiral muscle bundles 
encircling both ventricles [13] with the interventricular septum acting as a sort of ‘motor 
of biventricular function’ thanks to its endowment of fibres arising from both 
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ventricular chambers [14]. Because of ventricular interdependence, force is transmitted 
from one to the other ventricle through the myocardium independently from neural, 
humoral and haemodynamic influences, so that about 20–40% of the beat-to-beat right 
ventricular systolic pressure and volume outflow is conditioned by left ventricular 
contraction [12]. Not surprisingly, therefore, in the light of their intimate anatomic and 
functional connections, pressor stimuli exerted on one ventricular chamber are 
transmitted to the nonstressed counterpart. For example, LV haemodynamic 
overloading in experimental animals was accompanied by biventricular hypertrophy 
with augmented biochemical and haemodynamic function of the nonstressed RV [15]. 
Reciprocally, pulmonary banding increased mass and stiffness [16], augmented 
connective tissue synthesis [17] and reduced beta-adrenergic receptor density [18] not 
only in the overloaded RV but also in the haemodynamically uninvolved LV. 
 
II.b Pulmonary haemodynamics in systemic hypertension 
Following very early reports [19–21], the interest towards the behaviour of pulmonary 
haemodynamics in systemic hypertension was revived in 1977 by Atkins et al. [22] who 
showed increased pulmonary vascular resistance in 62% of 110 hypertensive patients on 
a variety of antihypertensive drug in presence of a positive correlation between 
pulmonary and systemic resistance suggestive of a common vasoconstrictor mechanism 
in the two vascular beds. A more detailed description of pulmonary haemodynamics in 
systemic hypertension was provided in 1978 by Olivari et al. [23] who showed higher 
pulmonary pressure and increased capillary wedge pressure in a group of hypertensive 
patients with LVH and strain at the electrocardiogram (EKG) as compared with 
normotensive controls. That finding was confirmed by Ferlinz [24] in 1980 in reporting 
both higher pressures in the right-sided heart (Fig. 2) and depressed RV function. 
However, both sets of data [23,24], consistent with increased pulmonary resistance 
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secondary to backward transmission of increased diastolic ventricular pressure in poorly 
compliant or failing LV (Fig. 3), resented of the inclusion of patients with more severe 
hypertension and advanced hypertensive cardiac damage. Consistent with that 
interpretation, studies in patients with atrial fibrillation showed larger ostial pulmonary 
vein diameter in hypertensive – than in normotensive patients (1.55±0.32 vs 1.43±0.26 
cm, P<0.01), a pattern worsened by coexisting LVH (1.66±0.37 cm) [25]. Highlighting 
further the importance of the clinical characteristics and stage of progression of 
hypertensive disease, the depressed RV ejection fraction reported by Ferlinz [24] 
through haemodynamic techniques contrasts with the normal RV function documented 
in subsequent studies by either radionuclide ventriculography [26] or echocardiography 
[27] including tricuspid annular plane systolic excursion (TAPSE) evaluation [28]. 
Interestingly, however, subtle disturbances of contractility emerged when tested by 
sophisticated echocardiographic techniques, such as strain/strain rate imaging [29], not 
influenced by global heart translation and adjacent myocardial segments tethering [30]. 
In addition, pulmonary resistance was normal in mildly hypertensive patients [31,32] 
implying normal left ventricular compliance and performance but also that –whatever 
hypertensinogenic factor affected the systemic circulation did not similarly affect the 
pulmonary circuit. Still, other studies [33,34] identified an elevated pulmonary 
resistance in absence of venous hypertension, an intriguing pattern compatible with the 
action of vasoconstrictor factors acting on both sides of the circulation. Thus, systemic 
hypertension may coexist with an apparently primary form of vasoconstriction in the 
lesser circulation in a subset of hypertensive patients, possibly under the influence of 
enhanced sympathetic tone, increased delivery of blood-borne vasoconstrictor 
substances or abnormal local release of vasoactive factors [7], perhaps promoted by an 
underlying insulin-resistant state [35]. Hyperreactivity to vasoactive stimuli is an 
additional feature of pulmonary arterioles in the presence of systemically elevated BP, 
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an evidence generated by Guazzi et al. [34] who reported greater pulmonary vasomotor 
responses evoked by both exogenous (Fig. 4, left panel) and endogenous sympathetic 
activation in response to cold, mental stress [36] and caval obstruction [32]. That 
hyperreactive pattern did not differ by baseline pulmonary resistance level [32 vs. 34] 
and could also be elicited by hypoxia [37] (Fig. 4, right panel), a nonadrenergicmediated 
vasoconstrictor stimulus [38]. That overall picture is compatible with the presence of 
early structural readaptation of pulmonary arterioles whose increased wall/lumen ratio 
can have a progressive pressor effect and accentuate nonspecifically the response to 
superimposed vasoconstrictor stimuli [7]. Exaggerated reactivity [39] and increased 
wall/lumen ratio [40] in the vascular bed of animal models of hypertension support that 
possibility though relevant human data are missing. Therefore, the question of whether 
the augmented vasoconstrictor reaction of pulmonary arterioles in human hypertension 
has a structural background or derives from functional abnormalities, for example, a 
systemically altered calcium ion metabolism of vascular smooth muscle cells [41], 
remains unanswered. 
 
II.c Echocardiographic evaluation of the right ventricle in systemic hypertension 
The application of M-mode echocardiography, though hampered by the geometric 
configuration of the RV and its heavily trabeculated anatomic structure with muscle 
bands, papillary muscle and chordae tendineae lying proximal to the right ventricular 
free wall [8], allowed Nunez et al. [27] in 1987 to show an increased right anterior wall 
thickness in patients with systemic hypertension and LVH (see Table 1 [26–29,42–46] 
for a synopsis of the available results). To that preliminary observation, Gottdiener et al. 
[42] added the important pathophysiological observation of RVH in conditions such as 
aortic stenosis in which left ventricular overload develops independent of heightened 
systemic BP levels. In that series, increased RV wall thickness exceeded the cut-off for 
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RVH in a large portion of the hypertensive group without relationship with right 
ventricular systolic pressure (Fig. 5, left panel). In agreement with Nunez et al. [27], a 
statistically significant correlation linked remodelling of the right and LVs though the 
regression of left over right wall thickness explained only about 60% of the overall data 
variability [42] (Fig. 5, right panel). The first documentation of RV diastolic 
dysfunction in hypertension was provided by Chakko et al. [43] in 1990 by 
documenting faster RV atrial filling, prolonged deceleration half-time, lower early/atrial 
filling velocity ratio and peak filling rate/stroke volume through pulsed wave Doppler 
echocardiography. That trend was confirmed by the other authors who subsequently 
addressed that issue [28,29,43–47] (see Table 1 for a synopsis of the available results). 
All studies reported a statistically significant association between RV and LV indices of 
diastolic filling (e.g. Fig. 6) without or, at its best, a poor relationship with anterior and 
posterior ventricular wall thickness as well as left ventricular mass. Galderisi et al. [46] 
and Cicala et al. [28] applied tissue Doppler analysis, a newer echocardiographic 
technique measuring intramyocardial velocities [48], to study right diastolic function in 
hypertensive patients. Both authors reported a prolonged RV relaxation time, an indirect 
measure of the active isometric relaxation phase, to indicate that the overall right 
ventricular diastolic interval is impaired during the course of systemic hypertension 
(Fig. 7, left panel and Table 1) through mechanisms independent of the degree of septal 
hypertrophy (Fig. 7, right panel). Because of its dependence upontransansvalvular 
pressor gradients [10,11], a delayed isometric relaxation time is consistent with an 
augmented pressor overload in the lesser circulation. In agreement with previous results 
[42], about one-third of the hypertensive group showed evidence of RVH (RV 
thickness> 5mm) [46]. 
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II.d Prehypertension: definition, epidemiology, cardiovascular subclinical disease and 
mortality  
The BP category “prehypertension” was first introduced by the Seventh Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (JNC-7) in 2003, replacing former categories of “high normal” and “above-
optimal” BP [49]. The rationale for redefining this category was to emphasize the 
excess risk associated with BP in this range and to focus increased clinical and public 
health attention on prevention. Regardless of terminology, this condition is a precursor 
of hypertension [50,51] and is associated with excess morbidity and deaths from 
cardiovascular causes [52,53]. Furthermore, an association of prehypertension with 
other cardiovascular risk factors has been established [54-57]. Prehypertension was 
defined as a systolic blood pressure of 120–139 mmHg and/or a diastolic blood pressure 
of 80–89 mmHg [49] (Table 2). 
A rationale basis for creating the prehypertension blood pressure category came, at least 
in part, from a metaanalysis that included approximately 1 million individuals from 61 
longterm epidemiological studies. The metaanalysis demonstrated that mortality from 
ischemic heart disease and stroke in individuals aged 40–89 years increases in a log–
linear relationship together with increases in both systolic and diastolic blood pressure 
[58] (Figure 8). For each 20 mmHg increase in systolic blood pressure or 10 mmHg 
increase in diastolic blood pressure over 115/75 mmHg, there is a twofold increase in 
mortality associated with coronary artery disease and stroke. Furthermore, longitudinal 
data from the Framingham Heart study indicated that individuals formerly classified as 
having ‘normal’ and ‘highnormal’ blood pressure (120–139/80–89 mmHg) are at 
increased risk of developing fullblown hypertension and cardiovascular disease later in 
life than those who have an optimal blood pressure (<120/80 mmHg) [51,59]. 
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In contrast with JNC-7, in 2007 the ESH-ESC Committee [60] has decided not to use 
the term ‘prehypertension’ for the following reasons: (1) even in the Framingham Heart 
study, the risk of developing hypertension was definitely higher in patients with high-
normal blood pressure than in those with normal blood pressure; (2) because of the 
serious meaning of the word hypertension for general populations, the term 
‘prehypertension’ might create anxiety and lead to unnecessary consultations with a 
doctor; (3) this category is a highly differentiated one in practice, with the extremes 
consisting of patients in no need of any intervention as well as of those with a very 
high-risk profile such as diabetes, chronic kidney disease, or hyperlipidemia for whom 
drug treatment is required, although lifestyle changes recommended by the JNC 7 for all 
prehypertensive individuals can be a valuable population strategy [60]. 
The publication of JNC-7 led to the initiation of population-based surveys to describe 
the prevalence of pre hypertension and increased awareness of the importance of the 
problem by doctors and health organizations. The Third National Health and Nutrition 
Examination Survey (NHANES III) 1999–2000 reported that the overall prevalence of 
prehypertension in the US was 31%, higher in men than in women, and was higher in 
obese than in normal weight persons [61]. On the basis of the NHANES 2005–2006 
data, an estimated 25% of the us population aged 20 years or older has prehypertension, 
including over 32 million men and 21 million women [62]. Prehypertension is 
associated with the same traditional cardiovascular risk factors as fullblown 
hypertension, such as obesity, diabetes mellitus and dyslipidemia. NHANES 1999–2000 
data showed that 64% of individuals with prehypertension had at least one other 
cardiovascular risk factor, and the percentage increased to 94% in those aged 60 years 
or older [61]. Prehypertension is associated with subclinical cardiovascular disease, 
including both microvascular and macrovascular pathology. Microalbuminuria, an 
organ-specific manifestation of generalized endothelial dysfunction that is associated 
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with increased risk of cardiovascular disease, is more common in individuals with 
prehypertension than in those with normal blood pressure [63-65]. Individuals with 
prehypertension often have subclinical atherosclerosis, manifested by increased 
common carotid artery intima-media thickness [66] and increased calcium deposition in 
the coronary arteries [67]. Prehypertension also accelerates the development of LVH 
and diastolic dysfunction. The population-based MONICA (Monitoring of trends and 
Determinations in Cardiovascular Disease) –Augsburg/KORA (Cooperative Research in 
the Region of Augsburg) study compared echocardiographic data from 119 individuals 
with prehypertension that persisted over the decade from 1994 or 1995 to 2004 or 2005 
with data from 142 individuals in whom blood pressure remained normal over this time 
[68]. Over these 10 years, prehypertensive individuals had a significantly greater age-
related increase in LV wall thickness (11.9% versus 4.7%, P <0.001) and LVM (15.7% 
versus 8.6%, p = 0.006) and an increased incidence of LV concentric remodeling 
(hazard ratio [HR] 10.7; 95% CI 2.82–40.4) and LVH (HR 5.3; 95% CI 1.58–17.9), 
compared with individuals with normal blood pressure. The ratio of peak early to late 
diastolic transmitral flow velocities decreased by 7.7% in patients with normal blood 
pressure compared with 15.7% in those with prehypertension (p = 0.003) and at follow-
up the ratio of peak early diastolic transmitral flow to peak early diastolic myocardial 
relaxation velocities was higher (9.1 versus 8.5, p = 0.031) and left atrial size was larger 
(36.5mm versus 35.3mm, p = 0.024) in prehypertensive than in normotensive 
individuals. The adjusted odds ratio for incident diastolic dysfunction was 2.52 (95% CI 
1.0–6.3) for the prehypertensive group. Thus, persistent prehypertension accelerates the 
development of LVH and diastolic dysfunction. 
Prehypertension has been associated with a variety of cardio-vascular diseases and with 
cardiovascular-associated and all-cause mortality in a number of large cohort studies. 
The increment in cardiovascular risk associated with progression from normotension to 
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prehypertension is similar to that associated with the progression from prehypertension 
to hypertension. In the MONICA study, participants who transitioned from 
normotension to the upper levels of prehypertension had the same increase in risk of 
cardiovascular events (HR 1.57; 95% CI 1.06–2.33) as those who progressed from the 
lower level of prehypertension to the hypertensive range (HR 1.64; 95% CI 1.19–2.26) 
[69]. A major objective of JNC-7 in creating the prehypertensive classification of blood 
pressure was to provide a tool for the identification of individuals for whom early 
adoption of a healthy lifestyle could lower blood pressure and prevent progression to 
hypertension, with associated reductions in target organ damage and cardiovascular 
events. Lifestyle modifications, such as weight loss, dietary alterations and exercise, 
have been shown consistently in randomized, controlled trials to effectively lower blood 
pressure and are recommended for patients with prehypertension [70-72]. Dietary 
modification can lower blood pressure effectively independently of weight loss in 
individuals with prehypertension. Treatment of prehypertensive patients with 
antihypertensive agents in addition to non-pharmacological measures has been explored 
in clinical trials. The Trial of Preventing Hypertension (TROPHY) study tested whether 
pharmacological treatment with the angiotensin II receptor antagonist candesartan 
cilexetil can prevent or delay the transition from prehypertension to stage 1 
hypertension [73]. Participants with prehypertension were randomly assigned to receive 
candesartan cilexetil or placebo for 2 years, followed by 2 years of placebo for all 
participants. In addition, all participants received instructions for lifestyle modification. 
During the first 2 years, the risk of developing hypertension was reduced by 66.3% in 
the participants who received candesartan cilexetil compared with the placebo group; 
the magnitude of risk reduction decreased to 16% by year 4, but was still statistically 
different from placebo. The treatment was also well tolerated. TROPHY provided the 
first demonstration that pharmacological treatment for patients with prehypertension is 
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safe and at least partially effective in reducing the risk of incident hypertension. 
However, no difference in the occurrence of cardiovascular events was observed 
between the treatment groups and the trial was not sufficiently powered to detect such a 
difference, had it occurred. Similarly to the TROPHY study, the Prevention of 
Hypertension with the ACE-inhibitor Ramipril in Patients with High Normal Blood 
Pressure (PHARAO) trial was a prospective, randomized, controlled study designed to 
analyze the effect of the angiotensin converting enzyme (ACE) inhibitor ramipril on 
preventing or delaying hypertension in 1,008 individuals with prehypertension [74]. 
Participants with pre hypertension were randomly assigned to receive ramipril or 
placebo and were followed for 3 years. Unlike TROPHY, PHARAO did not include a 
period of follow-up after withdrawal of active treatment. Hypertension developed in 
31% of participants in the ramipril group and 43% of those in the placebo group, with a 
statistically significant 34% reduction in risk for the ramipril group. The incidence of 
cerebrovascular and cardiovascular events was low and not significantly different 
between groups.  
In conclusion, individuals with prehypertension have an increased risk of fullblown 
hypertension, target organ damage and cardiovascular-related morbidity and mortality. 
Lifestyle modifications that lower blood pressure reduce morbidity and mortality 
associated with cardio-vascular events, and are recommended for all patients with 
prehypertension. Pharmacological treatment reduces progression from prehypertension 
to hypertension, but more studies are needed to determine the effects of 
pharmacological treatment on target organ damage and cardiovascular-related morbidity 
and mortality [75]. 
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II.e Tissue Doppler Imaging and Two-Dimensional Strain   
Tissue Doppler Imaging (TDI) is a relatively new echocardiographic technique 
originating from standard Doppler in order to obtain a quantitative analysis of 
myocardial function. Myocardial velocities and motions are tightly related to systolic 
and diastolic activity of the heart and are smaller (5-20 cm/sec) than blood velocities; 
TDI analysis is based on quantification of such parameters. While during standard 
echocardiographic examination low frequency myocardal tissue volocities are cutted out 
by default filters, in TDI examination blood flow high frequency are blocked by default 
filters or by color-based auto-correlation systems. Early reports by Isaaz et al showed 
the correspondance between TDI low myocardial velocities recorded at posterior side of 
mitral annulus and LV posterior wall alterated contractility [76]. Later on McDicken et 
al and Sutherland et al  enhanced previous systems by adding a direct color-Doppler 
view of myocardial wall movements [77,78]. Pulsed-wave TDI (PW-TDI) is usually 
performed on apical view to assess longitudinal motion of LV both at mitral annulus 
and myocardial wall level. Sampling at mitral annulus level allows a quantification of 
global systo-diastolic LV longitudinal shift, while myocardial wall sampling allows a 
direct analysis only of the sampled section. In all cases, the selection of a small sample 
volume (< 5mm) allow the detection of myocardial peak velocities (cm/sec) and of time 
intervals (msec). Myocardial TDI velocities vary according to ventricle anatomy being 
higher at cardiac base and lower at apex; so, to quantify myocardial function a cardiac 
base level measurement is recommended. American Society of Ecocardiography (ASE) 
recommends to place the sample volume at the junction of LV lateral wall with mitral 
annulus. Tissue-Doppler Imaging pattern showed two distinct “myocardial phases”: 
• A systolic phase including a forward systolic myocardial (Sm) velocity, an 
isovolumetric precontraction time (IPCT) and a contraction time (CT). 
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• A diastolic phase including an isovolumetric relaxation time (IVRT) and two 
backward myocardial diastolic velocities, early diastolic (Em) and atrial (Am). 
Notably, Em velocity demonstered to be a relatively pre-load independent index of 
myocardial relaxation. 
Two-dimensional strain (2Dstrain) imaging is a new technique which uses standard B-
mode images for speckle tracking analysis, in which the speckled pattern (acoustic 
backscatter generated by the reflected ultrasound beam) is followed frame by frame 
[79]. This speckle pattern is unique for each myocardial region and it is relatively stable 
throughout the cardiac cycle. The displacement of this speckled pattern is considered to 
follow myocardial movement and a change between speckles represents myocardial 
deformation. When tracking a defined region of speckles, a software algorithm follows 
the change in geometric position of this region, frame by frame, and extracts the 
displacement, velocity, strain and strain rate of a defined myocardial segment (Figure 
9). In contrast to TDI derived parameters, speckle tracking is an angle independent 
technique as the movement of speckles can be followed in any direction. For the apical 
views this implies that not only longitudinal, but also transverse parameters can be 
calculated, which is not possible in TDI recordings. In short axis images both 
circumferential and radial parameters can be calculated for all myocardial segments. In 
addition to the circumferential deformation parameters, ventricular rotation 
and twist (additional parameters for LV function) can also be calculated using this 
technique [80,81]. Since the deformation parameters can be calculated in two 
dimensions (while TDI derived parameters are one-dimensional), this technique is often 
referred as two-dimensional strain echocardiography (2DSE). Validation of early 
versions of 2DSE software in a tissue mimicking gelatin block revealed a good 
correlation compared to sonomicrometry, although values (both strain and strain-rate) 
were overestimated in the lower range of values [82]. These findings were also found in 
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an animal model (sonomicrometry in pigs with myocardial infarction), where 2DSE was 
found to slightly overestimate values compared to the reference test. A weaker 
correlation was found in the lower range of deformation values [82]. Tracking is 
affected by dyskinetic segments (e.g. ischemia), causing the fiber orientation to change, 
thus affecting acoustic properties and speckle integrity. Using a new (two-stage) 
tracking algorithm, a better correlation was found between the 2DSE values and those 
obtained using sonomicrometry over the entire broad range of tested clinical relevant 
values [83]. For radial and circumferential parameters, a good correlation was found 
using sonomicrometry in dogs [84]. The first study to determine the feasibility and 
accuracy of 2DSE in patients with myocardial infarction reported that of all segments, 
98% in the control population and 80% in the patient group could be analyzed, findings 
which were reproduced in later studies [84]. Importantly, 2DSE data are highly 
reproducible and analysis is affected by only small intraobserver (mean 4.4 (SD 1.6)%) 
and interobserver variability (7.3 (SD 2.5)%) [85]. Values were significantly reduced in 
the infarcted segments, implying a reduction in systolic deformation. There was no 
significant difference between TDI and 2DSE parameters [86]. In a direct comparison 
of TDI and 2DSE with MRI-tagging as a reference, comparable values were found for 
2DSE and TDI in both normal and dysfunctional segments. For radial measurements, 
2DSE was more reliable than TDI [87]. At present, the optimal frame rate for speckle 
tracking seems to be 50–70 frames per second (FPS), which is lower compared to TDI 
(>180 FPS): this could result in undersampling, especially in patients with tachycardia.      
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STUDY AIMS 
 
The right-sided cardiovascular system is not immune to the effect of systemic 
hypertension.  Consistent echocardiographic evidence (see Table 1 for a synopsis of the 
available data) indicates that systemic hypertension associates with thickened wall of 
the RV, a central element of the low-pressure system. RV remodelling develops in 
parallel with a similar process at the left side, likely as a result of ventricular 
interdependence [12] driven by vasoactive and trophic factors, including sympathetic 
stimulation and locally released substances such as angiotensin II and endothelin(s) [2], 
targeting both myocardial walls. That explanation is not exclusive, though, and other 
pathophysiological mechanisms including primarily or secondarily increased pulmonary 
afterload maybe operative as well. Available evidences originate from studies carried 
out on hypertensive models or subjects but no data as so far been reported on the effects 
of a mild increase of BP on RV structure and function. On these grounds, we designed 
the present study to analyze the effect(s) of such a mild increase on RV.  
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PATIENTS AND METHODS 
 
IV.a Study population 
Ninety-eight never-treated asymptomatic patients (see Table 3 for demographics and 
clinical characteristics of the overall sample) without history of any disease, with 
normal physical examination and no abnormalities at routine biochemical tests 
participated in the study. The group included 30 controls with optimal BP (casual BP 
<120/80mmHg) and 68 patients referred for hypertension screening to our outpatient 
clinic. Inclusion criteria required fasting plasma glucose below 126 mg/dl, serum 
creatinine less than 1.2mg/dl, no proteinuria at the dipstick test, negative urinocolture, 
normal sediment, ejection fraction above 50%, no evidence or history of lung disease, 
congestive cardiac failure and/or left ventricular dysfunction, ischemic heart disease, 
atrial fibrillation and clinically significant valvular defect (<2 on a 1–4 ordinal scale) at 
Doppler recordings. Patients with office BP above 160/100mmHg and body mass index 
(BMI) above 30 kg/m2 were excluded. In all, renal ultrasound scans showed normal-
sized kidneys and no evidence of cortical scarring or obstructive uropathy, whereas 
routine clinical and biochemical evaluation excluded other secondary forms of 
hypertension.  
 
IV.b Experimental procedures 
Anthropometric measurements (height and weight) were made after each participant had 
removed his shoes and upper garments. Blood samples were obtained between 08:00 
and 09:00 AM after overnight fasting and 15 minutes of supine rest. Twenty-four-hour 
BP was measured using a validated [88] oscillometric monitor (Diasys Integra, 
Novacor) on a regular work day. Recording began between 08:30 and 09:00 AM with 
readings every 15 min until midnight, and every 30 min from midnight to 08:00 AM 
 21
with at least 90% valid measurements. Office pressures were the mean of at least three 
recordings taken at the time of the echocardiographic study. Total, low-density 
lipoprotein (LDL), high-density lipoprotein (HDL)-cholesterol, triglycerides were 
assessed by enzymatic colorimetric techniques (Boehringer-Mannheim), fasting plasma 
glucose by the glucooxidase method using a Beckman Glucose Analyzer II (Beckman 
Instruments), and plasma insulin by immunoradiometric assay (Biosource; no cross-
reactivity with human proinsulin, between-assay variation coefficient of 5%).  
 
IV.c Conventional echocardiograpy 
Monodimensional and bidimensional echocardiograms were obtained according to the 
recommendations of the Joint American and European Society of Echocardiography 
[89] using standard parasternal and apical views through a machine (Vivid 7; General 
Electric Healthcare) equipped with a harmonic 4.0-MHz variable-frequency phased-
array transducer. The LV end-diastolic diameter (LVEDD), LV end-systolic diameter 
(LVESD), end-diastolic thickness of ventricular septum (IVSThd), end-diastolic 
thickness of LV posterior wall (PWThd) and of RV free wall (RWThd) were measured 
by M-mode echocardiography. Using these parameters, we calculated LV mass and the 
relative LV wall thickness as follows: LV mass (g) = 1.04 × ((LVEDD + IVSThd + 
PWTh)3 − LVEDD3) − 13.6. Relative LV wall thickness (RWT) = 2 × PWThd/LVEDD. 
Left ventricular mass (LVM) index was determined by dividing the LV mass 
measurement by the body surface area (g/m2) (LMVbs) or by height (LVMh) (h2.7). LV 
end-diastolic volume (LVEDV) and end-systolic volume (ESV) were calculated from 
the apical 2- and 4-chamber views using a modified Simpson’s method. LV ejection 
fraction was calculated as ejection fraction (LVEDV–LVESV)/LVEDV × 100. 
Endsystolic left atrial dimensions were measured in the parasternal axis view from the 
trailing edge of the posterior aortic–anterior left atrial complex [89]. TAPSE, an index 
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of RV systolic function [90] was measured as tricuspid annulus plane systolic excursion 
during the same cardiaa cycle (mm). Systolic pulmonary artery pressure (SPAP) was 
estimated through the modified Bernoulli equation adding a constant 5mmHg as a 
standard measure of right atrial pressure [91]. Tricuspid and mitral inflow velocities 
were obtained by pulsed-wave Doppler echocardiography positioning a sample volume 
between outflow tract and valve leaflet tips in the apical four-chamber view. Inflow 
measurements included peak velocity (cm/s) during early (E) and late (A) filling, their 
ratio (E/A ratio), E-wave deceleration time and isovolumic relaxation time (IVRT) (ms) 
[92]. 
 
IV.d Tissue Doppler and Two-Dimensional Strain echocardiography  
Pulsed-wave TDI was performed with a variable frequency, phased-array transducer 
(2.5MHz), bypassing the high-pass filter to display tissue velocities. Gains were 
minimized to allow a clear tissue signal with minimal background noise aligning the 
echo image to the annular motion. From the apical four-chamber view, the Doppler 
sample volume (20-mm axial length) was placed at the lateral tricuspid annulus as well 
as at the septal and lateral mitral annulus. The Nyquist limit was adjusted to a velocity 
range of 1.5–15cm/s. The monitor sweep speed was set at 50–100mm/s to optimize the 
spectral display of myocardial velocities. For the assessment of global longitudinal LV 
systo-diastolic function we acquired and measured by PW-TDI the mitral annulus 
systolic (s′) and early (e′) and late (a′) diastolic velocities at septal and lateral sides. 
Outcome RV measures were peak systolic (Sm), early (Em) and late (Am, 
corresponding to the wall motion caused by atrial systole) later tricuspid annular 
diastolic velocities (cm/s) [93] averaged over five consecutive cardiac cycles at end-
expiratory apnea with the patients in partial left decubitus. All tissue Doppler 
echocardiography measurements were recorded on site and read off-line by three skilled 
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operators blindly to clinical and echocardiographic data. The average within and 
between-observer percentage of error for velocity measurements was 3 and 9%, 
respectively [94].  
For 2Dstrain analysis, RV and IVS longitudinal strain (ε, i.e. the per cent systolic 
deformation relative to the diastolic value) and strain rate (SR, i.e. deformation velocity, 
s-1) were obtained by blinded sonographers from apical four-chamber views at the end 
of expiration and breath holding. Images were acquired at an 80s-1 frame rate and stored 
digitally on a hard disk for offline analysis by speckle-tracking methodology from 2D 
grey-scale images. Image analysis was performed offline on a PC workstation using 
custom analysis software (Echopac PC, Version 6.0.X; GE Healthcare, Fairfield, CT). ε 
values were generated according to the spatial and temporal shift of the corresponding 
acoustic markers rejecting segments of poor quality, despite manual correction. 
For LV analysis, we acquired LV short-axis views at the apical, mid, and basal levels, 
and LV apical two- and four-chamber views using a high-frame rate (80 frames/s). The 
basal shortaxis view contained the mitral valve, the mid short-axis view contained the 
chordae tendineae, and the apical short-axis view was acquired distal to the papillary 
muscles. At each plane, three consecutive cardiac cycles were acquired at end expiration 
breath holding and stored digitally on a hard disk for offline analysis. The LV 
endocardial border of the end-systolic frame was manually traced. Once traced this line, 
the computer automatically created a region of interest including the entire transmutably 
wall for all patients, and the software selected natural acoustic markers moving with the 
tissue. Automatic frame-by-frame tracking of these markers during cardiac cycle (2D 
systolic time interval method) yielded a measure of rotation, rotational velocity, strain, 
and strain rate at any point of myocardium. The LV was divided into 16 segments, and 
each segment was individually analyzed [86]. 2D LV strain, strain rate, and rotation 
were measured using a dedicated software package. In the present study, longitudinal 
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strain and strain rate were assessed in the six LV walls on the apical 2-chamber view 
and in the six LV walls on the apical four-chamber view. Circumferential strain and 
strain rate were assessed in the six LV walls on the parasternal LV short-axis view at 
the level of the chordae tendineae, and their average values were used for comparison. 
Radial strain and strain rate were assessed in the six LV walls on the parasternal LV 
shortaxis view at the level of the chordae tendineae [95]. The sonographers were 
blinded from the subject belonging BP group. The intraclass correlation coefficient (ri) 
was calculated according to Bland and Altman’s procedure [96]. Three values of 2D 
strain were sampled for each patient and for each septal and lateral mid segment: the 
correlation coefficient (ri) for septal was 0.87 and for lateral it was 0.88.  
For RV analysis, region of interest was the lateral mid-RV segment and results were 
averaged over three consecutive cardiac cycles. Pulmonary valve closure delimited RV 
peak ε. No patient showed evidence of post-systolic peak. Evaluation variables were 
longitudinal peak ε and systolic SR (SSR) (as measures of systolic function and 
contractility, respectively) and early (ESR) and late (ASR) diastolic SR (as indices of early 
myocardial relaxation and late ventricular filling, respectively) (Figure 10). Within-
observer variability (n = 10 triplicates by the same observer) was 8.1, 10.3, 7.3, and 
8.2% (mean variation coefficients) for RV peak ε, SSR, ESR, and ASR, respectively. The 
corresponding values for between-observer variability (n = 5 replicates by each of the 
three sonographers) were 11.1, 12.9, 10.9, and 11% respectively. 
 
IV.e Data processing 
Mitral annular velocities were the average of septal and lateral mitral annular 
measurements, as recommended by recent consensus documents [97]. Mid-wall 
fractional shortening (MDFS) was the index of ventricular systolic function accounting 
for the epicardial migration of the LV midwall during systolic myocardial contraction 
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[89]. Left ventricular mass index (LVMI) was calculated according to the Penn 
Convention indexed by height2.7, the power that linearizes the relation between LVM 
and body height. LVH was defined as LVMI above 51 g/m2.7 and concentric LVH was 
diagnosed if relative wall thickness [RWT, calculated as 2*PWT/LVEDD] was greater 
than 0.42 [89]. Insulin sensitivity was assessed through the homeostasis model 
assessment (HOMA) [98].  
 
IV.f Statistical analysis 
Study variables were stratified by 24-h systolic BP tertiles (cut-offs: 117, 130mmHg) 
and between-group differences were tested by Bonferroni’s method for multiple 
comparisons. The strength of association was tested through Spearman’s ρ correlation 
coefficients and distribution of categorical parameters by χ2 statistics. Descriptive 
statistics were arithmetic means±standard deviation (SD) or medians (interquartile 
range) for skewed data. Statistical significance was set at p <0.05. 
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RESULTS 
 
V.a Right and left ventricle behaviour by ascending systolic blood pressure   
Age, sex distribution, BMI, lipids, fasting plasma glucose, insulin, HOMA (Table 3), 
SPAP, TAPSE, MDFS, EDD, left atrial dimensions (Table 4) and transvalvular Doppler 
indices of RV and LV diastolic function (Table 5) did not differ by 24-h SBP tertiles. 
IVS thickened gradedly, although still within normal limits, by increasing systemic 24-h 
SBP, whereas PW remodeled to a lesser extent poorly related to the systemic BP load; 
RV wall thickness did not change (Fig. 11). LVMI and RWT increased but the trend 
reached the formal limits of statistical significance only for the latter parameter (Table 
4). LVH was present in nine patients (9%), only two (2%) of whom with RWT above 
0.42, the cut-off for concentric LVH. RV thickness exceeds 5 mm in only three (3%) 
subjects. 
As compared with the bottom normotensive third, tricuspid Em was reduced to a highly 
significant extent in the mid, high-normal 24-h SBP stratum and slowed further in the 
upper mildly hypertensive third in which also Sm was lower; Am did not change (Fig. 
12, left panel). Data sampled at the mitral annulus showed similar trends (Fig. 12, right 
panel). On an intraindividual basis, peak systolic (Sm) and early diastolic tricuspid (Em) 
velocity values intercorrelated (rho = 0.60, P<0.001, n = 98) and both associated 
inversely with IVST (Fig. 13, left and right panel). The correlations with PWT (-0.19 
and -0.25, respectively) and LVMI (-0.09 and -0.20, respectively) were either not 
significant or of definitely lower strength. Positive and statistically significant 
correlations existed between peak tricuspid velocities and the homologous mitral 
parameters (Em: rho = 0.48, Sm: rho = 041, P<0.001 for both, n = 98). 
Mid-tertile RV and IVS peak ε and ESR were lower than the referent group without 
further changes in the upper 24-h SBP third (Figure 14, top left and right panels). Right 
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ventricular SSR and ASR did not significantly change in contrast to significant trends to 
decrease and increase, respectively, at the mid-septum (Figure 14, bottom left and right 
panels). Right ventricular strain peak ε and ESR  were inverse correlates of IVS thickness 
(ρ = -0.36 and -0.40, respectively, p < 0.001, n = 89) and a similar intra-individual 
association existed for mid-septal samplings (peak ε: ρ = -0.32, p = 0.002; SSR : -0.34, p 
< 0.001; ESR: -0.40, p < 0.001; ASR: 0.28, p = 0.007, n = 89). 
At LV level, 2D longitudinal systolic strain appeared significantly lower both at mid 
septum and mid lateral level in relation to SBP increase, in comparison with lower 
tertile (p < 0.002). Also the analysis of longitudinal 2D strain rate, essentially at septum 
level, confirmed a progressive impairment both of systolic and diastolic parameters by 
ascending SBP. Instead the radial and circumferential 2D systolic strain functions were 
comparable in all three tertles and in all LV segments. Even considering only the 
patients with LVM within normal values (in both middle an upper tertile), we found that 
the same previously described structural and functional abnormalities were present, but 
in a milder expression. It was relevant that the demographic, clinic, and echo-Doppler 
conventional parameters of the subgroup with normal LVM were super imposable with 
those of lower BP group. 
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DISCUSSION  
 
Some preliminary comments about the experimental design adopted in this study, which 
aimed at the evaluation of the functional inter-relationship between RV function and 
systemic BP levels in early uncomplicated hypertension, will facilitate the discussion of 
the results and their pathophysiological implications. First, we recruited healthy, never-
treated, lean patients excluding patients with both moderate-to-severe hypertension to 
minimize the chance of hypertensive heart disease [99] and obesity because of its 
confounding noxious influence on RV and LV function [100,101]. Their metabolic 
profile was screened in the light of recent suggestions about a role for impaired insulin 
sensitivity in the genesis of increased pulmonary resistance [35] and ventricular systolic 
and diastolic dysfunction in early hypertension [102] and other normotensive 
phenotypes of the metabolic syndrome [103]. Second, ventricular function was assessed 
by TDI in apical views, a technique that, by extending Doppler applications to the 
measurement of myocardial wall motion, measures longitudinal diastolic and systolic 
function by and large independent of preload, afterload and heart rate [94,100,101]. 
Third, we reported only data about systolic myocardial deformation along the 
longitudinal axis because this is the only reliable determination allowed by the thin RV 
structure [104]. For the sake of clarity, analysis of IVS mechanics was limited to 
longitudinal shortening, although abnormalities of the radial and circumferential 
components [105] may co-exist in early hypertension [102]. Moreover, we restricted 
strain analysis to the mid-RV segment that, as reported for IVS [106], could not reflect 
the overall behaviour of the RV, an additional limitation to be taken in mind. Fourth, BP 
load was assessed by 24-h monitoring rather than office determinations because of its 
greater power in predicting hypertensive cardiac damage (e.g. [107]), focusing on SBP 
values because of their greater association with cardiac remodeling and myocardial 
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oxygen demands [108]. Finally, tertile stratification by 24-h SBP separated a lower 
optimal BP third (24-h SBP <117mmHg) from an intermediate highnormal (24-h SBP 
117–30mmHg) partition and an upper (24-h SBP >130mmHg) stratum of patients with 
established, mildly elevated hypertension [60].  
Within that specific experimental context, the reduced Em in the mid, high-normal BP 
tertile constitutes, at least to our knowledge, the first demonstration of an association 
between increments in systemic BP levels still below the conventional threshold of 
arterial hypertension and impaired RV relaxation. RV diastolic abnormalities might 
plausibly anticipate a weakening systolic contractility at least in those patients with 
high-normal BP bound to evolve towards established arterial hypertension [73], but this 
is only a speculative possibility since crosssectional studies cannot establish temporal 
sequences. On the contrary, the appearance of a delayed systolic velocity combined with 
a further deceleration of the diastolic component in the upper hypertensive tertile 
indicates the sensitivity of global RV function to varying peripheral afterload, 
somewhat discrepant from previous TDI studies of RV function in systemic 
hypertension showing no change in systolic velocity [28,29]. However, our results are 
consistent with data obtained by more refined echocardiographic techniques such as 
ultrasonic strain and strain rate [29]. Notably, RV abnormalities at TDI examination 
coexisted with unchanged TAPSE, a marker of RV systolic function [90], and trans-
tricuspidal Doppler indices of diastolic function [92], in line with the known greater 
capability of TDI to detect subclinical diastolic and systolic functional changes 
[93,100,101]. 
2D-strain results confirm TDI data about the occurrence of subclinical systolic and 
diastolic RV dysfunction at the very early stages of arterial hypertension. However, 
abnormalities in RV mechanics did not overlap, though, with those of IVS characterized 
by changes in all strain parameters (peak ε, SSR, ESR , and ASR) as a function of 
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increasing systemic afterload. Whether that difference originates from technical 
problems related, for example, to the peculiar anatomical pattern of the RV [9] or 
deeper pathophysiological determinants is unclear. Still, cross-sectional studies such as 
ours and statistical associations are not informative about cause– effect relationships 
and the reasons why increasing systemic BP influences RV function remain unknown. 
An obvious question is why mild increments in systemic BP should affect the RV, a 
structure not directly exposed to the systemic BP load, even more in absence of 
evidence for secondary RV overload as a consequence of transmission to the pulmonary 
circuit of raised LV diastolic pressure [11]. In fact, the neutral behavior of both LA size 
and transmitral Doppler parameters, two well recognized indices of LV diastolic 
function [92,109], excluded clinically significant LV diastolic dysfunction, a negative 
inference corroborated by the absence of concentric LVH, a close associate of 
abnormalities of that kind [99]. Increased pulmonary pressure raising in parallel to 
heightened systemic resistance has been invoked as a pathogenic mechanism in some 
patients with essential hypertension [22,33], but we found neither increased SPAP nor 
RV wall hypertrophy to support that theory. Other investigators reported in the past 
similarly negative data [31], although an increased pulmonary reactivity to 
vasoconstrictor stimuli [32] cannot be excluded on the basis of resting determinations. 
Whether different results would be obtained in presence of an insulin-resistant status, as 
suggested by previous animal studies [35], is an interesting issue that our study cannot 
address since HOMA, a surrogate measure of insulin sensitivity [98], as well as the 
other phenotypic hallmarks of the insulin resistance syndrome [110], were in the normal 
range as expected in preselected lean, nondiabetic patients. If hemodynamic overload 
could not explain our findings, a viable alternative could be offered by the behavior of 
the interventricular septum, a structure involved in both RV ejection and filling [111] 
and ventricular interdependence, that is the transmission of forces from one to the other 
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ventricle independent of neural, humoral or circulatory influences [12]. In consonance 
with that view, RV systolic and diastolic velocities decreased by increasing septal 
thickness and both correlated with the homologous indices measured at the mitral level. 
2D-strain analysis add confirmatory data. In fact, decreasing RV peak ε and ESR 
associated quite strongly with BP-driven remodelling of IVS, a ‘bilayered’ structure 
sharing fibres with both ventricles [112] that contributes to RV ejection and filling and 
ventricular interdependence[111]. 
Importantly, septal remodeling did not exceed conventional limits for hypertrophy 
suggesting that thickness per se was not a critical determinant of impaired RV function 
in agreement with reports of preserved TDI velocity indices in patients with 
hypertrophic cardiomyopathy and extremely hypertrophied septa [113]. In turn, IVS 
acted as the afterload-transducing cardiac structure by thickening as a linear function of 
systemic BP, a divergent behavior from posterior wall and LVMI explained by the 
peculiar bending radius, the additive burden of RV load and, perhaps, higher sensitivity 
to humoral stimuli [106,114]. As a further extrapolation, one might also infer that the 
diastolic and systolic components of RV dysfunction shared probably some common 
pathophysiological background given their high statistical correlation. Still, cross-
sectional studies such as ours and statistical associations are not informative about 
cause–effect relationships and the precise reasons by which increasing systemic BP 
influences RV function remain unknown. Additional mechanistic insight might 
theoretically derive from multiple linear regression analyses accounting for the several 
clinical and echocardiographic correlates of the RV function. However, reliable 
conclusions from that approach require the independence of predictor variables, a rare 
occurrence in observational studies such as ours in which multicollinearity introduces 
biases and makes conclusions uncertain [115].  
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An additional point worth of comment relates to the emerging differences between the 
observed 2D-strain imaging results and those obtained by TDI analyses of tricuspid 
annular motion. In fact, the impaired systolic function (reduced peak ε) in subjects with 
high-normal 24-h SBP contrasted with the preserved tricuspid peak systolic annular 
motion velocity by TDI. On the same line, the unchanged early myocardial relaxation 
(ESR) in the transition from high-normal to hypertensive BP values is at odds with the 
further deceleration of peak early diastolic tricuspid annular motion evaluated by 
velocity echocardiography.  Those discrepancies are not surprising given the intrinsic 
heterogeneity of the two methods [79] and the complexities of cardiac function. 
Whatever the case, it is important to note that abnormal strain imaging co-existed with 
unchanged global markers of systolic (TAPSE) [90] and diastolic (transvalvular 
diastolic Doppler indices) [92] function, confirming the potential of deformation 
imaging in the detection of subclinical RV dysfunction [116]. 
Our results could represent an initial rational basis for some future clinical applications 
of echocardiographic evaluation of the RV in pre- and/or hypertension. First, 
prehypertensive subjects showing RV impairment could progress to hypertension faster 
than those without RV involvement so taking advantage on a closer echocardiographic 
and clinical follow-up. Moreover, if this assumption will be confirmed, such patient 
category will probably benefit from early pharmacological treatment. Second, even in 
really hypertensive patients RV dysfunction could identify a sub-population with an 
higher incidence rate of heart failure and could benefit from more intensive BP lowering 
strategies. Lastly, RV functional and structural changes could be used to monitor the 
efficacy of any BP lowering intervention; it could be hypothesized that RV dysfunction 
could reverse with the return of BP level into the normal range.  
However, any of these putative clinical implication warrants an appropriate prospective 
validation on a specific and larger population within a clinical trial.      
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Although focused primarily on RV abnormalities, our TDI data are of interest also in 
confirming previous data about the early appearance of hypertensive LV diastolic and 
systolic dysfunction in prehypertensive [117] and uncomplicated hypertensive 
individuals [118]. Moreover, subclinical LV dysfunction, both systolic and diastolic, 
coexisted with an unchanged insulin sensitivity, as indirectly assessed by HOMA index 
[98], a piece of evidence putting in less stringent perspectives the link between 
metabolic derangements and cardiac abnormalities reported by others in the early stage 
of hypertension [102] and other phenotypes of the insulin resistance syndrome [103]. 
Moreover, we found several structural and functional LV systolic and diastolic 
abnormalities by 2D strain echocardiography in relation to BP increase similar, even of 
a lesser extent, to hypertensive patients, whose abnormalities are nevertheless more 
severe. In fact, we observed a progressive significantly lower longitudinal 2D systolic 
deformation at septum and LV lateral wall level that parallels SBP increase and these 
abnormalities are present even considering patients in middle and upper tertiles with 
normal LVM. 
In conclusion, high-normal and mildly increased systemic BP is accompanied by 
combined systolic and diastolic RV dysfunction, an abnormality to which 
interventricular septum remodeling may contribute in the light of its crucial role in the 
pathophysiology of that ventricular chamber. Further studies are needed to understand 
in full the determinants and the clinical relevance of that phenomenon, in particular the 
interaction between mildly increased BP and obesity as well as the effect of early 
antihypertensive interventions on RV function. 
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